The ACAD chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ACAD chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The ACAD stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
View ACAD Detailed Price Forecast - CNN Money | View ACAD Detailed Summary - Google Finance | ||
View ACAD Detailed Summary - Yahoo! Finance | View ACAD Stock Research & Analysis - Zacks.com |
View ACAD Trends & Analysis - Trade-Ideas | View ACAD Major Holders - Barrons | ||
View ACAD Call Transcripts - NASDAQ | View ACAD Breaking News & Analysis - Seeking Alpha | ||
View ACAD Annual Report - CompanySpotlight.com | View ACAD OTC Short Report - OTCShortReport.com | ||
View ACAD Fundamentals - TradeKing | View ACAD SEC Filings - Bar Chart | ||
View Historical Prices for ACAD - The WSJ | View Performance/Total Return for ACAD - Morningstar | ||
View the Analyst Estimates for ACAD - MarketWatch | View the Earnings History for ACAD - CNBC | ||
View the ACAD Earnings - StockMarketWatch | View ACAD Buy or Sell Recommendations - MacroAxis | ||
View the ACAD Bullish Patterns - American Bulls | View ACAD Short Pain Metrics - ShortPainBot.com |
View ACAD Stock Mentions - StockTwits | View ACAD Stock Mentions - PennyStockTweets | ||
View ACAD Stock Mentions - Twitter | View ACAD Investment Forum News - Investor Hub | ||
View ACAD Stock Mentions - Yahoo! Message Board | View ACAD Stock Mentions - Seeking Alpha |
View Insider Transactions for ACAD - SECform4.com | View Insider Transactions for ACAD - Insider Cow | ||
View ACAD Major Holdings Summary - CNBC | View Insider Disclosure for ACAD - OTC Markets | ||
View Insider Transactions for ACAD - Yahoo! Finance | View Institutional Holdings for ACAD - NASDAQ |
View ACAD Stock Insight & Charts - FinViz.com | View ACAD Investment Charts - StockCharts.com | ||
View ACAD Stock Overview & Charts - BarChart | View ACAD User Generated Charts - Trading View |
Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Posted on Friday April 19, 2024
SAN DIEGO, April 19, 2024--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that on April 10, 2024, the Compensation Committee of Acadia’s Board of Directors (the "Committee") granted inducement awards consisting of non-qualified stock options to purchase 21,659 shares of common stock and 12,739 restricted stock units ("RSUs") to six new employees under Acadia’s 2023 Inducement Plan. The Compensation Committee approved the awards as an inducement material to the new employees’ employme
Acadia Pharmaceuticals Presents New DAYBUE™ (trofinetide) Clinical Data at the 2024 American Academy of Neurology (AAN) Annual Meeting
Posted on Wednesday April 17, 2024
SAN DIEGO, April 17, 2024--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that two oral presentations featuring DAYBUE™ (trofinetide) findings in Rett syndrome will be presented at the American Academy of Neurology (AAN) 2024 annual meeting, being held this week in Denver, CO.
3 Pharma Stocks to Sell in April Before They Crash & Burn
Posted on Thursday April 11, 2024
There are some pharma stocks to sell in April. Holding these companies is too risky, especially as the industry faces increasing regulatory scrutiny and pricing pressures. Several major pharmaceutical firms are grappling with patent cliffs, where key drug exclusivities are expiring. This opens the door for generic competition. Moreover, with the broader market presenting attractive investment options, holding on to these riskier pharma plays could result in significant opportunity cost. Many pro
ACADIA Pharmaceuticals Inc CEO Stephen Davis Sells 26,574 Shares
Posted on Tuesday April 09, 2024
ACADIA Pharmaceuticals Inc (NASDAQ:ACAD), a biopharmaceutical company focused on the development and commercialization of medicines to address unmet medical needs in central nervous system disorders, has reported an insider sell transaction.